The safety of sodium-glucose co-transporter 2 inhibitors in patients with left ventricular assist device - a single center experience.
Journal of cardiovascular medicine (Hagerstown, Md.)（2023）
摘要
SGLT2 inhibitors are safe in patients with LVAD and may potentially improve cardiovascular and renal outcomes in this special population.
更多查看译文
关键词
left ventricular assist device,inhibitors,sodium-glucose,co-transporter
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要